ArticleSensors (Basel, Switzerland)2023
Saliency Map and Deep Learning in Binary Classification of Brain Tumours.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment.Frontiers in immunology · 2026Review
- AI-Powered Histology for Molecular Profiling in Brain Tumors: Toward Smart Diagnostics from Tissue.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The paper was devoted to the application of saliency analysis methods in the performance analysis of deep neural networks used for the binary classification of brain tumours. We have presented the basic issues related to deep learning techniques. A significant challenge in using deep learning methods is the ability to explain the decision-making process of the network. To ensure accurate results, the deep network being used must undergo extensive training to produce high-quality predictions. There are various network architectures that differ in their properties and number of parameters. Consequently, an intriguing question is how these different networks arrive at similar or distinct decisions based on the same set of prerequisites. Therefore, three widely used deep convolutional networks have been discussed, such as VGG16, ResNet50 and EfficientNetB7, which were used as backbone models. We have customized the output layer of these pre-trained models with a softmax layer. In addition, an additional network has been described that was used to assess the saliency areas obtained. For each of the above networks, many tests have been performed using key metrics, including statistical evaluation of the impact of class activation mapping (CAM) and gradient-weighted class activation mapping (Grad-CAM) on network performance on a publicly available dataset of brain tumour X-ray images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.